Loading...
Docoh

Galecto (GLTO)

Utility
Amorphous Form of 5-BROMOPYRIDIN-3-YL 3-DEOXY-3-[4-(3,4,5-TRIFLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL]-1-THIO-ALPHA-D-GALACTOPYRANOSIDE
3 Mar 22
A stabilized amorphous form of a compound of formula I as well as compositions for oral administration including the compound of formula I in a therapeutically effective amount.
Lise GRAVELLE, Peter TIMMINS, Anders PEDERSEN
Filed: 18 Dec 19
Utility
Novel Galactoside Inhibitor of Galectins
20 Jan 22
A compound of the general formula (1).
Fredrik ZETTERBERG, Kristoffer PETERSON, Karl JANSSON
Filed: 15 Nov 19
Utility
Prodrug Galactoside Inhibitor of Galectins
9 Dec 21
A prodrug compound of the general formula I or II.
Fredrik ZETTERBERG, Ulf NILSSON
Filed: 9 Oct 19
Utility
Galactoside Inhibitor of Galectins
9 Dec 21
A compound of the general formula I or II.
Fredrik ZETTERBERG, Ulf NILSSON, Thomas BRIMERT, Kristoffer PETERSON, Karl JANSSON
Filed: 9 Oct 19
Utility
Novel Galactoside Inhibitor of Galectins
16 Sep 21
An α-D-galactopyranose compound of the general formula (1).
Fredrik ZETTERBERG
Filed: 24 May 21
Utility
Idiopathic Pulmonary Fibrosis-detection, Monitoring, Prediction Methods
22 Jul 21
Neil HENDERSON, Tariq SETHI, Alison MACKINNON, Hakon LEFFLER, Ulf NILSSON
Filed: 2 Apr 21
Utility
Galactoside inhibitor of galectins
29 Jun 21
An α-D-galactopyranose compound of the general formula (1).
Fredrik Zetterberg
Filed: 9 Jan 19
Utility
Alpha-D-galactoside inhibitors of galectins
27 Apr 21
The present invention relates to a compound of the general formula (1).
Fredrik Zetterberg, Hakon Leffler, Ulf Nilsson
Filed: 9 Jul 17
  • 1
Patents are sorted by USPTO publication date, most recent first